Source: Annual Congress 2006 - COPD exacerbations
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
W. Perera, J. Hurst, T. Wilkinson, G. Donaldson, J. Wedzicha (London, United Kingdom). Serum C-reactive protein 14 days after a COPD exacerbation and time to the next exacerbation. Eur Respir J 2006; 28: Suppl. 50, 1083

Member's Comments

No comment yet.

Related content which might interest you: The importance of C-reactive protein in patients with acute exacerbation of severe COPD Source: International Congress 2019 – Airway disease-associated exacerbations Year: 2019 Increased serum endotoxin levels as biomarker in acute exacerbations of COPD. Source: International Congress 2018 – Biomarkers of COPD Year: 2018 Procalcitonin versus C-reactive protein in the management of severe acute exacerbations of COPD Source: Annual Congress 2010 - Aetiology and outcomes of infective exacerbations of COPD Year: 2010 Serum magnesium levels in acute exacerbation of COPD Source: Annual Congress 2007 - Exacerbations of COPD Year: 2007 C-reactive protein level and microbial aetiology in patients hospitalised with acute exacerbation of COPD Source: Eur Respir J 2015; 45: 76-86 Year: 2015 Activin-A levels in sputum and serum of COPD, asthma and ACOS patients during acute exacerbation and at baseline Source: International Congress 2017 – Infection and exacerbation science Year: 2017 Serum interleukin-6 levels correlate with malnutrition in patients with acute exacerbation of COPD Source: Annual Congress 2009 - Organisation of care for individuals with chronic respiratory disease Year: 2009 C-reactive protein usefulness in diagnosis and follow-up of COPD infectious exacerbations Source: Annual Congress 2007 - Different aspects of COPD exacerbations Year: 2007 Thromboprophylaxis and the relationship between C-reactive protein and plasma fibrinogen in patients with acute exacerbations of COPD Source: Eur Respir J 2007; 30: Suppl. 51, 555s Year: 2007 Are C-reactive protein levels associated with bacteria in COPD exacerbations? Source: Eur Respir J 2015; 45: 1514-1515 Year: 2015 Are C-reactive protein levels associated with bacteria in COPD exacerbations? Source: Eur Respir J 2015; 45: 1515-1516 Year: 2015 COPD, asthma and C-reactive protein Source: Eur Respir J 2006; 27: 874-876 Year: 2006 Time course of serum interleukin-6 during COPD exacerbations Source: Eur Respir J 2004; 24: Suppl. 48, 305s Year: 2004 Time course of sputum and serum interleukin-6 during COPD exacerbations Source: Eur Respir J 2005; 26: Suppl. 49, 464s Year: 2005 Evaluation of procalcitonin (PCT) and neopterin levels in acute exacerbations of COPD Source: Annual Congress 2005 - Acute and chronic infections in COPD Year: 2005 Procalcitonin and C-reactive protein levels in infective attacks of COPD Source: Eur Respir J 2003; 22: Suppl. 45, 337s Year: 2003 Analysis of IgE and C-reactive protein as possible predictors of exacerbation patients with asthma Source: Annual Congress 2011 - Biomarkers of allergic inflammation Year: 2011 Serum SP-A and SP-D levels in patients admitted to the hospital with acute COPD exacerbation Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016 Relationship between CRP levels and the severity of COPD acute exacerbations among group D COPD patients. Source: Virtual Congress 2020 – COPD phenotypes Year: 2020 Combined serum eosinophil count and procalcitonin level as a marker of bacterial infection in acute exacerbation of chronic obstructive pulmonary disease Source: International Congress 2016 – Systemic biomarkers Year: 2016